PepRank

Noopept

Also: Omberacetam · GVS-111 · N-phenylacetyl-L-prolylglycine ethyl ester

Peptide-derivedMoodNeuroprotectionNasal / Sublingual / Oral

Dipeptide-derived racetam-like nootropic; mild focus and creativity aid, cheap.

Safety tier
Caution
strict bar
Positive
39%
of 50 reports
Per month
≈ €0.34–0.68
nasal
Rank
#1
of 1 peptide-derived entries

At a glance

Access
Grey market
SublingualFelt in 0–40 min
NasalFelt in 0–40 min
OralFelt in 0 min – 1 h
Lasts 1–4 h
Best effects
Easier sustained concentration · faster creative/writing work · presence, less brain fog · stimulant synergy
Downsides
Headache (often attributed to low choline) · irritability at high doses · insomnia in sensitive users · poor oral bioavailability
Typical use
10-30 mg/day sublingual (or 5-10 mg nasal), split 1-2x, not daily indefinitely.
Stacked with
Stacked with
Choline (alpha-GPC or CDP-choline): Most often added on the belief it prevents noopept headaches; a few users find the extra choline itself causes fatigue, reflux or low mood. · Caffeine or prescription stimulants (Adderall, modafinil): Commonly used as an adjunct: users say it adds processing and recall to the stimulant's drive, though one reports irritability at interruptions. · L-theanine: Taken alongside to blunt the edginess or anxiety some get from noopept.

Safety

Tier by safety barStrict CautionBalanced CautionEvidence only Caution
  • Seen harm1 of 3
  • Mechanism1 of 3
  • Data gap1 of 3
  • Silent harm1 of 3
  • Product2 of 3
Never if
Severe liver or kidney impairment (label) · Pregnancy or breastfeeding (label) · Under 18 (label) · Uncontrolled hypertension
Why each score
Seen harm 1/3
Russian trials and an 18-study review report only mild, transient adverse events. Two first-hand reports describe lasting harm (derealization and anhedonia over seven weeks, and memory loss), which are isolated and unverified. Clinical efficacy of omberacetam in adults with cognitive impairment: systematic review, 18 studies, n=1,279 (2026) ↗r/anhedonia: Noopept-induced derealization and anhedonia persisting 7+ weeks ↗r/anhedonia: Noopept gave 'terrible memory loss' ↗
Mechanism 1/3
A dipeptide prodrug of cycloprolylglycine that raises hippocampal NGF and BDNF in rats; no pathway to serious harm is established, and the label's only notable reaction is a rise in blood pressure in people with hypertension. Ostrovskaya et al. 2008: Noopept raises NGF and BDNF expression in rat hippocampus (PubMed 19240853) ↗Noopept, Russian label (Vidal) ↗
Data gap 1/3
An over-the-counter drug in Russia with controlled trials (largest n=150) and a 1,279-patient systematic review of mostly open-label studies. Dadasheva 2022: omberacetam vs piracetam/cinnarizine in vascular cognitive impairment, n=150 ↗Clinical efficacy of omberacetam in adults with cognitive impairment: systematic review, 18 studies, n=1,279 (2026) ↗
Silent harm 1/3
Headache, overstimulation and mood effects are felt within hours, though the rare dissociative reports lingered for weeks. r/anhedonia: Noopept-induced derealization and anhedonia persisting 7+ weeks ↗
Product 2/3
Unapproved in the US and EU, so people buy powders, capsules and nasal sprays from nootropic vendors; US 'cognitive' supplements tested held up to four times the drug dose, 75% of declared amounts were wrong and some carried undeclared drugs. Omberacetam and other unapproved drugs in US 'cognitive' supplements (PubMed 34484905) ↗

User reports

All 53 reports →
Users report
Mixed-to-positive: 'roughly the recreational value of a cup of coffee' but easier sustained focus, sometimes reduced anxiety; strongly route-dependent (oral often does nothing, sublingual/nasal works). Perhaps 35-45% notice little. Common complaints are headaches and irritability at higher doses and insomnia for sensitive users. A small tail report anhedonia, dissociation or brain fog after a dose, usually gone in days but in one case lasting weeks.
Glowing 5Positive 14Mixed 7Nothing 15Negative 6Bad reaction 3
  • r/MaladaptiveDreaming· · 9 upvotesOriginal ↗

    I took noopept for two months, and not only I was able to sleep like a god and stay focused for hours: my daydreams were decreased by more tan 70% in terms of time, and the needing of daydream almost dissapeared.

    Glowingbelow the recommended dose · 2 months

    maladaptive daydreaming

  • r/MCAS· · 3 upvotesOriginal ↗

    I started in 2022 in an effort to counter brain fog and the results were pretty astonishing. ... I'm almost sixty but I feel that thanks to this stuff I have the mental capabilities I had when I was half my age.

    Glowing30 mg sublingual 3x/day in month-long courses, now about weekly · Sublingual · yearly 1-month courses since 2022

    MCAS brain fog, age ~60

  • r/NooTopics· · 17 upvotesOriginal ↗

    I dont remember it having much effect for me back in the day

    Nothing

Where to buy

All 23 offers →
Getting it
Over-the-counter drug in Russia; unapproved in the US and EU, sold online as powder, capsules or nasal spray with unreliable labelling.

A month at 5–10 mg/day nasal costs ≈ €0.34–0.68 from Semax Polska at €2.25/g. By mouth, from €0.68.

Cheapest from trusted shops in the EU

ShopPackPricePer mgPer monthTesting
Semax PolskaEU · PL
Trust 4/5Each product shows an Analiza Białek (Wrocław) HPLC report naming its operator Dobre Peptydy sp. z o.o. as the client, with a verification password (Semax 60 mg: 62.18 mg, 99%), and Reddit buyers since 2024 report fast, professional deliveries; the only complaints are about felt effect.Ships to France for €14, 1–5 days.COAs ↗
powder · 10000 mg€23€2.25/g≈ €0.68–2 a monthThird-party tested

Studies

Evidence
Approved drug in Russia (Noopept 10 mg tablets); small human RCTs in vascular cognitive impairment
Caveat
Not really a peptide: a dipeptide-derived prodrug (to cycloprolylglycine). Over-the-counter supplement status in many countries; no serious safety signal in the Russian literature.
2 more studies and 2 sources

Sources

Molecule

Modifications
not a true peptide: N-phenylacetyl-L-prolylglycine ethyl ester (modified dipeptide ester)

Sequence

The peptide's chain of amino acids from its start (the N-terminus) to its end, one bead and one letter for each: A alanine, C cysteine, D aspartic acid, E glutamic acid, F phenylalanine, G glycine, H histidine, I isoleucine, K lysine, L leucine, M methionine, N asparagine, P proline, Q glutamine, R arginine, S serine, T threonine, V valine, W tryptophan, Y tyrosine. A modification such as an N-acetyl cap or a C-terminal amide changes how long it lasts in the body. Length tells related peptides apart, from a two-residue dipeptide like carnosine to a 43-residue protein like thymosin beta-4, and predicts neither effect nor safety.

Report grades

Every first-hand Reddit or X report is graded on its own, from glowing through positive, mixed, nothing and negative to bad reaction, and the bar shows how those grades split. Posts that look vendor-adjacent stay on the peptide's page but are left out of the counts.

GlowingPositiveMixedNothingNegativeBad reaction

% positive

The share of a peptide's graded Reddit and X reports that are glowing or positive, vendor-adjacent posts left out. A peptide with few reports is pulled toward the average of all reports, as if it had eight average ones besides its own, so two glowing posts cannot top the list. Peptides rank by this figure, those with no graded report yet after those with one, and Avoid ones after every other entry.

Researcher estimate

No first-hand report of this peptide has been graded yet, so the figure is the researchers' own rating out of 10 from what they read about it. It ranks after every peptide with graded reports until its own arrive.

Safety tier

Each peptide is tiered Clean, Caution or Avoid from its five risk axes under the chosen safety bar. An Avoid peptide carries a real risk of harm, a plausible route to serious harm rather than mere unpleasantness, so it stays listed with the reason but ranks behind every other entry, however good its reviews.

Safety bar

The safety bar sets how much risk it takes to rate a peptide Avoid. Strict: out on any serious mechanism with little human data, or any documented serious harm. Balanced: out on documented serious harm (unless it is obvious, reversible and from a regulated product), or a serious mechanism whose harm would be silent with no human data at all. Evidence only: out only on documented serious harm in humans that is lasting, delayed or from grey-market product.

Seen harm

Documented serious adverse events in humans, from 0 for none despite real exposure to 3 for deaths or several well-documented serious harms. Serious means a hospital or emergency visit or harm lasting weeks, so a headache or a bad night does not count.

Mechanism

A plausible biological route to serious harm at the doses people use, such as growth-factor signalling, hormone-axis suppression, heart or blood-pressure effects or immune activation. It runs from 0 when none is known to 3 when a dangerous pathway has been shown in living animals.

Data gap

How little human safety data exists for the molecule actually sold, from 0 for an approved drug with large trials and years of use to 3 for no human safety data at all. A modified analogue does not inherit its parent's trials.

Silent harm

Whether the feared harm would show quickly or stay hidden, from 0 when it is obvious and goes on stopping to 3 when it is silent and delayed, like tumour promotion or slow organ damage. User reports cannot reveal a harm that takes years to appear, so a high score here limits what good reviews can tell you.

Product

The risk of what people actually buy, from 0 for a regulated pharmacy or supplement product taken by mouth or on the skin to 3 for a grey-market injectable. In one dataset of 6,441 grey-market samples, 42–71% failed basic quality criteria and 15% carried endotoxin; taken by mouth or in the nose, a pack avoids the injection risks.

Evidence

The strongest kind of study behind the peptide's effects, from an approved drug through human controlled trials and small human studies to animal work or nothing of its own. Animal results often fail to carry over to people.

Access

How people get it: as an approved drug, a compounded prescription, an over-the-counter supplement or from the grey market, where nobody checks the vial. The channel decides both the legal position and the risk of a bad batch.

Price per month

Thirty days of the typical dose, from its low end to its high end, priced at the listing a careful buyer would choose: in stock, from a shop scoring 4 of 5 on trust (third-party tested where no score is set), failing that 3, a pure pack before a blend, a European shop first, then the cheapest per mg. The range is the dose's, not the shops'. A per-dose amount counts once a day unless the dose says otherwise. Prices are in euros at ECB rates of 2026-10-29, before shipping; the shop table keeps each listing's price per mg, per gram for bulk supplements. Where no listing can be priced the researchers' own estimate stands in, and says so.

Dose users report

The middle half of the daily doses stated in at least five first-hand reports, vendor posts left out. Where its middle sits more than twice above or below the declared dose, the month is priced at it as well, since what people take is what they pay for.

Shop trust

Each shop's trust on a 1–5 scale, read from its testing and its reputation: 1 for serious red flags (fabricated COAs, scam reports, impersonation, a closed shop), 2 for no public testing, a new shop or active complaints such as seized parcels, 3 for its own COAs or a short track record, 4 for verified third-party testing or a strong reputation, and 5 for third-party batch reports that name the shop, with years of good independent reputation. A shop without a score counts third-party batch testing as 4, its own COAs as 3 and no public tests as 2.

Best value

Within a category or a goal, a peptide that no other beats on both counts: none is rated more positively for the same or a lower monthly price, and none costs less for the same or a higher rating. The chart joins these into the best-value line; the cheapest of them and the best-rated of them both make it, so the line spans the trade-off from cheap to best. Avoid entries never count, and a peptide needs both a % positive and a price to be compared.

Testing

Whether the shop publishes lab results: third-party tested means an independent lab checks each batch, own COA means the shop's own certificate of analysis, and no public tests means neither. A certificate shows purity, not safety.

Added peptide

Some packs sold under one peptide's name hold a second one, such as 5 mg GHK-Cu in a nasal kit, stated only in the description. Sprayed in the nose or injected it reaches the blood like an injection, so it carries the risk of that route and is tiered as the injectable form, whatever its tier on the skin. A pack whose page gives no contents list may hold more than its name.